LitCovid-sample-Enju  

PMC:7205724 / 10726-11458 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T94687 0-1 DT denotes A
T22655 2-7 NN denotes pilot
T19573 8-13 NN denotes study
T23972 14-15 -LRB- denotes [
T55337 15-17 CD denotes 11
T96728 17-18 -RRB- denotes ]
T92410 19-27 RB denotes recently
T26265 28-31 VBZ denotes has
T35997 32-44 VBN denotes investigated
T92380 45-48 DT denotes the
T38590 49-55 NN denotes safety
T37156 56-59 CC denotes and
T24661 60-66 NN denotes effect
T94632 67-69 IN denotes of
T56352 70-82 JJ denotes convalescent
T65134 83-89 NN denotes plasma
T64844 90-94 WDT denotes that
T95987 95-102 VBP denotes contain
T86655 103-111 NN denotes antibody
T45118 112-118 NNS denotes levels
T26321 119-125 JJR denotes higher
T17226 126-130 IN denotes than
T2522 131-132 CD denotes 1
T48589 132-133 -COLON- denotes :
T90182 133-136 CD denotes 640
T89317 137-145 VBN denotes combined
T28925 146-150 IN denotes with
T68950 151-158 JJ denotes regular
T58621 159-169 JJ denotes anti-viral
T22929 170-176 NNS denotes agents
T50644 177-180 CC denotes and
T63224 181-189 JJ denotes standard
T22041 190-200 JJ denotes supportive
T89053 201-205 NN denotes care
T94835 206-208 IN denotes on
T20257 209-217 JJ denotes clinical
T49329 218-226 NNS denotes outcomes
T91601 227-229 IN denotes of
T6238 230-233 CD denotes ten
T3048 234-242 NNS denotes patients
T18696 243-247 IN denotes with
T93206 248-254 JJ denotes severe
T71443 255-263 NN denotes COVID-19
T46997 265-268 DT denotes The
T7672 269-274 NN denotes study
T83098 275-281 VBD denotes showed
T5017 282-290 JJ denotes clinical
T96870 291-302 NN denotes improvement
T42442 303-305 IN denotes of
T61149 306-309 PDT denotes all
T89276 310-313 DT denotes the
T53728 314-317 CD denotes ten
T50396 318-326 NNS denotes patients
T59179 327-338 VBN denotes accompanied
T83510 339-341 IN denotes by
T2183 342-344 DT denotes an
T4240 345-353 NN denotes increase
T18383 354-356 IN denotes in
T99269 357-367 NN denotes lymphocyte
T12131 368-373 NN denotes count
T36613 374-377 CC denotes and
T91622 378-379 DT denotes a
T39579 380-388 NN denotes decrease
T72559 389-391 IN denotes in
T31686 392-395 NN denotes CRP
T20580 397-406 VBG denotes Following
T23341 407-418 NN denotes transfusion
T23846 419-421 IN denotes of
T23496 422-434 JJ denotes convalescent
T68740 435-441 NN denotes plasma
T74721 441-442 -COMMA- denotes ,
T3255 443-446 PDT denotes all
T47829 447-450 DT denotes the
T16466 451-456 CD denotes seven
T26913 457-465 NNS denotes patients
T47643 466-469 WP denotes who
T10299 470-474 VBD denotes were
T19318 475-484 NN denotes SARS-CoV2
T2642 485-488 NN denotes RNA
T76428 489-497 JJ denotes positive
T59448 498-504 IN denotes before
T49967 505-516 NN denotes transfusion
T2352 517-519 IN denotes of
T3020 520-532 JJ denotes convalescent
T57517 533-539 NN denotes plasma
T55829 540-546 VBD denotes turned
T39392 547-556 NN denotes SARS-CoV2
T26456 557-565 JJ denotes negative
T52249 567-572 EX denotes There
T13795 573-577 VBD denotes were
T15563 578-580 DT denotes no
T53693 581-588 NN denotes control
T35357 589-595 NNS denotes groups
T16756 596-605 VBG denotes receiving
T53621 606-618 JJ denotes convalescent
T81904 619-625 NN denotes plasma
T11852 626-631 RB denotes alone
T58859 632-634 CC denotes or
T35171 635-643 JJ denotes standard
T39367 644-651 NN denotes therapy
T20306 652-659 IN denotes without
T63670 660-672 JJ denotes convalescent
T44856 673-680 NN denotes therapy
T15733 681-683 TO denotes to
T71428 684-692 VB denotes evaluate
T29390 693-696 DT denotes the
T54708 697-701 JJ denotes main
T64138 702-708 NN denotes effect
T21425 709-711 IN denotes of
T75685 712-724 JJ denotes convalescent
T78861 725-731 NN denotes plasma
R10830 T45118 T86655 arg1Of levels,antibody
R11811 T44856 T20306 arg2Of therapy,without
R12375 T2642 T10299 arg2Of RNA,were
R12539 T22929 T50644 arg1Of agents,and
R14919 T26456 T39392 arg1Of negative,SARS-CoV2
R19448 T2642 T19318 arg1Of RNA,SARS-CoV2
R20207 T57517 T3020 arg1Of plasma,convalescent
R20951 T19573 T35997 arg1Of study,investigated
R22133 T78861 T75685 arg1Of plasma,convalescent
R22469 T64138 T21425 arg1Of effect,of
R23710 T2642 T76428 arg1Of RNA,positive
R24725 T26913 T10299 arg1Of patients,were
R2474 T64138 T29390 arg1Of effect,the
R25087 T23341 T20580 arg2Of transfusion,Following
R2541 T50396 T59179 arg2Of patients,accompanied
R26123 T16756 T20306 arg1Of receiving,without
R27767 T68740 T23496 arg1Of plasma,convalescent
R29016 T16756 T15733 modOf receiving,to
R2931 T49967 T2352 arg1Of transfusion,of
R30054 T2522 T48589 arg1Of 1,:
R30096 T26913 T55829 arg1Of patients,turned
R30895 T50396 T53728 arg1Of patients,ten
R32394 T22929 T58621 arg1Of agents,anti-viral
R32731 T38590 T37156 arg1Of safety,and
R32883 T89053 T50644 arg2Of care,and
R33735 T64138 T71428 arg2Of effect,evaluate
R34116 T49329 T91601 arg1Of outcomes,of
R34529 T10299 T59448 arg1Of were,before
R36266 T26913 T16466 arg1Of patients,seven
R3822 T57517 T2352 arg2Of plasma,of
R38806 T4240 T2183 arg1Of increase,an
R4008 T48589 T17226 arg2Of :,than
R40479 T71443 T18696 arg2Of COVID-19,with
R40530 T71428 T15733 arg1Of evaluate,to
R40627 T37156 T94632 arg1Of and,of
R40867 T7672 T83098 arg1Of study,showed
R42101 T26913 T47643 arg1Of patients,who
R42168 T55337 T23972 arg2Of 11,[
R45762 T90182 T48589 arg2Of 640,:
R48507 T81904 T58859 arg1Of plasma,or
R48725 T31686 T72559 arg2Of CRP,in
R49718 T26913 T26456 arg1Of patients,negative
R49789 T26913 T3255 arg1Of patients,all
R49835 T35357 T53693 arg1Of groups,control
R50628 T50396 T89276 arg1Of patients,the
R50969 T26321 T17226 arg1Of higher,than
R51409 T3048 T18696 arg1Of patients,with
R51479 T50396 T61149 arg1Of patients,all
R52082 T19573 T94687 arg1Of study,A
R52864 T96870 T42442 arg1Of improvement,of
R5522 T3048 T91601 arg2Of patients,of
R55615 T7672 T46997 arg1Of study,The
R56320 T36613 T59179 arg1Of and,accompanied
R56840 T64138 T54708 arg1Of effect,main
R57531 T39367 T35171 arg1Of therapy,standard
R58957 T48589 T94835 arg1Of :,on
R59105 T44856 T63670 arg1Of therapy,convalescent
R60141 T49967 T59448 arg2Of transfusion,before
R60332 T50644 T28925 arg2Of and,with
R60391 T12131 T99269 arg1Of count,lymphocyte
R61261 T45118 T26321 arg1Of levels,higher
R64658 T96870 T83098 arg2Of improvement,showed
R65194 T19573 T22655 arg1Of study,pilot
R65241 T81904 T53621 arg1Of plasma,convalescent
R65706 T19573 T26265 arg1Of study,has
R66056 T96870 T5017 arg1Of improvement,clinical
R66336 T23341 T23846 arg1Of transfusion,of
R66579 T26456 T55829 arg2Of negative,turned
R67249 T37156 T95987 arg1Of and,contain
R67798 T39579 T91622 arg1Of decrease,a
R68506 T35357 T13795 arg2Of groups,were
R69272 T24661 T37156 arg2Of effect,and
R69387 T22929 T68950 arg1Of agents,regular
R70060 T50396 T42442 arg2Of patients,of
R70070 T52249 T13795 arg1Of There,were
R70225 T45118 T95987 arg2Of levels,contain
R7103 T58859 T16756 arg2Of or,receiving
R73729 T65134 T94632 arg2Of plasma,of
R7377 T37156 T64844 arg1Of and,that
R73941 T35997 T26265 arg2Of investigated,has
R74118 T3048 T6238 arg1Of patients,ten
R74990 T39367 T58859 arg2Of therapy,or
R75573 T49329 T94835 arg2Of outcomes,on
R77420 T12131 T18383 arg2Of count,in
R7749 T78861 T21425 arg2Of plasma,of
R78448 T35997 T92410 arg1Of investigated,recently
R7895 T65134 T56352 arg1Of plasma,convalescent
R79010 T55829 T74721 arg1Of turned,","
R80186 T36613 T83510 arg2Of and,by
R80896 T81904 T11852 arg1Of plasma,alone
R82541 T39579 T72559 arg1Of decrease,in
R83087 T37156 T35997 arg2Of and,investigated
R83808 T55829 T20580 arg1Of turned,Following
R84751 T89053 T22041 arg1Of care,supportive
R85485 T39579 T36613 arg2Of decrease,and
R87348 T89317 T28925 arg1Of combined,with
R88768 T35357 T16756 arg1Of groups,receiving
R90019 T71443 T93206 arg1Of COVID-19,severe
R9016 T68740 T23846 arg2Of plasma,of
R94657 T35357 T15563 arg1Of groups,no
R95106 T19573 T23972 arg1Of study,[
R95339 T96728 T23972 arg3Of ],[
R95922 T4240 T36613 arg1Of increase,and
R97536 T37156 T92380 arg1Of and,the
R98083 T26913 T47829 arg1Of patients,the
R98484 T49329 T20257 arg1Of outcomes,clinical
R9880 T4240 T18383 arg1Of increase,in
R9970 T48589 T89317 arg2Of :,combined
R99734 T89053 T63224 arg1Of care,standard